Reversibility of regorafenib effects in hepatocellular carcinoma cells.
D'Alessandro R, Refolo MG, Lippolis C, Messa C, Cavallini A, Rossi R, Resta L, Di Carlo A, Carr BI.
D'Alessandro R, et al.
Cancer Chemother Pharmacol. 2013 Oct;72(4):869-77. doi: 10.1007/s00280-013-2269-8.
Cancer Chemother Pharmacol. 2013.
PMID: 23959464
Free PMC article.